General Information of Drug (ID: DM2DERW)

Drug Name
ELN-864709 Drug Info
Synonyms ELN-330977; ELN-678033; JNK3 inhibitors (neuronal injury), Elan; JNK3 inhibitors (neuronalinjury/neurodegenerative disease); JNK3 inhibitors (neuronal injury/neurodegenerative disease), Elan
Indication
Disease Entry ICD 11 Status REF
Central nervous system injury KA40 Investigative [1]
Cross-matching ID
TTD Drug ID
DM2DERW

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Patented Agent(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
PMID25991433-Compound-A1 DM89LF0 N. A. N. A. Patented [2]
PMID25991433-Compound-F2 DM37VIQ N. A. N. A. Patented [2]
7-azaindole derivative 1 DMQL5B7 N. A. N. A. Patented [2]
7-azaindole derivative 5 DMV3H98 N. A. N. A. Patented [2]
PMID25991433-Compound-P6 DMNDVC9 N. A. N. A. Patented [2]
PMID25991433-Compound-J3 DM17P3F N. A. N. A. Patented [2]
PMID25991433-Compound-P1 DMD8AX6 N. A. N. A. Patented [2]
PMID25991433-Compound-O3 DMVOWS5 N. A. N. A. Patented [2]
PMID25991433-Compound-J2 DMZSOCK N. A. N. A. Patented [2]
7-azaindole derivative 3 DMQ7BV4 N. A. N. A. Patented [2]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Stress-activated protein kinase JNK3 (JNK3) TT056SO MK10_HUMAN Inhibitor [1]

References

1 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 1498).
2 c-Jun N-terminal kinase inhibitors: a patent review (2010 - 2014).Expert Opin Ther Pat. 2015;25(8):849-72.